Two Sigma Investments, LP Rapt Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

$40.3 Billion
Q1 2024

A detailed history of Two Sigma Investments, LP transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 425,603 shares of RAPT stock, worth $1.71 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

425,603

Previous 32,641 1203.89%

Holding current value

$1.71 Million

Previous $811,000 371.15%

% of portfolio

0.01%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$6.87 - $26.45 $2.7 Million - $10.4 Million	392,962 Added 1203.89%	425,603 $3.82 Million
Q4 2023 Feb 14, 2024	BUY	$11.28 - $25.46 $153,870 - $347,299	13,641 Added 71.79%	32,641 $811,000
Q3 2023 Nov 14, 2023	SELL	$16.34 - $24.66 $450,984 - $680,616	-27,600 Reduced 59.23%	19,000 $315,000
Q2 2023 Aug 14, 2023	SELL	$16.06 - $21.61 $275,589 - $370,827	-17,160 Reduced 26.91%	46,600 $871,000
Q1 2023 May 15, 2023	BUY	$17.19 - $30.8 $741,920 - $1.33 Million	43,160 Added 209.51%	63,760 $1.17 Million

Q4 2022 Feb 14, 2023	BUY	$16.28 - $24.6 $335,368 - $506,760	20,600 New	20,600 $407,000
Q2 2022 Aug 15, 2022	SELL	$10.26 - $23.59 $687,296 - $1.58 Million	-66,988 Reduced 85.02%	11,800 $215,000
Q1 2022 May 16, 2022	SELL	$17.02 - $40.22 $999,567 - $2.36 Million	-58,729 Reduced 42.71%	78,788 $1.73 Million
Q4 2021 Feb 14, 2022	SELL	$29.5 - $39.5 $2.18 Million - $2.92 Million	-73,819 Reduced 34.93%	137,517 $5.05 Million
Q3 2021 Nov 15, 2021	BUY	$29.86 - $39.47 $253,153 - $334,626	8,478 Added 4.18%	211,336 $6.56 Million
Q2 2021 Aug 16, 2021	BUY	$17.99 - $40.02 $3.05 Million - $6.79 Million	169,758 Added 512.86%	202,858 $6.45 Million
Q1 2021 May 17, 2021	SELL	$16.0 - $24.46 $172,800 - $264,168	-10,800 Reduced 24.6%	33,100 $735,000
Q4 2020 Feb 16, 2021	BUY	$15.89 - $40.87 $484,057 - $1.25 Million	30,463 Added 226.71%	43,900 $867,000
Q3 2020 Nov 16, 2020	BUY	$21.6 - $37.5 $290,239 - $503,887	13,437 New	13,437 $433,000

Others Institutions Holding RAPT

# of Institutions

148

Shares Held

29.2M

Call Options Held

709K

Put Options Held

1.06M

View Full List

About RAPT Therapeutics, Inc.

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $119M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

More about RAPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Rapt Therapeutics, Inc. Transaction History